2014 ESC GUIDELINES ON DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY

2014 ESC GUIDELINES ON DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY

.

Saved in:

Bibliographic Details
Main Authors:	Perry M. Elliott, Aris Anastasakis, Michael A. Borger, Martin Borggrefe, Franco Cecchi, Philippe Charron, Albert Alain Hagege, Antoine Lafont, Giuseppe Limongelli, Heiko Mahrholdt, William J. McKenna, Jens Mogensen, Petros Nihoyannopoulos, Stefano Nistri, Petronella G. Pieper, Burkert Pieske, Claudio Rapezzi, Frans H. Rutten, Christoph Tillmanns, Hugh Watkins, Constantinos O’Mahony
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-05-01
Series:	Российский кардиологический журнал
Subjects:	guideline diagnosis cardiac imaging genetics symptoms heart failure arrhythmia left ventricular outflow tract obstruction sudden cardiac death implantable cardioverter defibrillators pregnancy athletes hypertension valve disease
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/229
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)

2018 ESC Guidelines for the diagnosis and management of syncope
by: Michele Brignole, et al.
Published: (2019-08-01)

Resting heart rate assessed within clinical practice demonstrates no prognostic relevance for defibrillator recipients in the German DEVICE registry
by: Fares-Alexander Alken, et al.
Published: (2024-11-01)

2015 ESC GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS AND THE PREVENTION OF SUDDEN CARDIAC DEATH
by: Priori G. Silvia, et al.
Published: (2016-07-01)

Management of Gunshot Injury Involving Cardiac Implantable Electronic Device
by: Saad A. Ali, DO, et al.
Published: (2025-07-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
by: I. V. Talibullin, et al.
Published: (2022-04-01)

Return‐to‐play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta‐analysis
by: Rifqi Rizkani Eri, et al.
Published: (2025-08-01)

Digitalis Therapy Is Associated With an Increased Risk of ICD Shock Delivery and Device Revision
by: Gerrit Frommeyer, et al.
Published: (2025-05-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01)

CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01)

Sudden cardiac death and decompensation of heart failure: how to reduce the risks. A review
by: Marina V. Kuleshova, et al.
Published: (2025-01-01)

Cardiac resynchronization therapy: potential for arrhythmic risk modification
by: N. N. Ilov, et al.
Published: (2023-06-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

National Tunisian Multicenter Prospective Study on Cardiac Implantable Electronic Devices (Tunisian NATURE-CIED study): One-year complications and predictive factors
by: Sonia Chabrak, MD, et al.
Published: (2025-08-01)

CLINICAL OPINION: BRUGADA SYNDROME AND SICK SYNUS SYNDROME — CASE WHICH WE MEET IN OUR PRACTICE
by: Tomislav Kostic, et al.
Published: (2014-01-01)

Turbulence and deceleration capacity of the heart rate in patients with coronary artery disease and implanted cardioverter defibrillator
by: N. V. Melnik, et al.
Published: (2019-08-01)

Brugada Syndrome and Exercise: Is It Time for a Paradigm Change?
by: Carolina Miguel Gonçalves, et al.
Published: (2025-03-01)

Fever as a Catalyst for Life‐Threatening Arrhythmias in Brugada Syndrome: A Rare Case of Brugada Syndrome Unmasked in a Young Male
by: Ibrahim Khalil, et al.
Published: (2025-07-01)

Clinical characteristics of various arrhythmogenic cardiomyopathy phenotypes in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-12-01)

Protocol of randomized controlled trial to evaluate the effect of moderate exercise training on the functional capacity of patients with an implantable cardioverter defibrillator in a tertiary care center in South India
by: Selvakumar Paramasivan, et al.
Published: (2024-11-01)

2016 ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE
by: Piotr Ponikowski, et al.
Published: (2017-02-01)

2015 ESC GUIDELINES FOR THE MANAGEMENT OF INFECTIVE ENDOCARDITIS
by: Gilbert Habib, et al.
Published: (2016-05-01)

2014 ESC/ESA GUIDELINES ON NON-CARDIAC SURGERY: CARDIOVASCULAR ASSESSMENT AND MANAGEMENT
by: (ESC) European Society of Cardiology, et al.
Published: (2015-08-01)

Contemporary medical therapy, sex-specific characteristics, and outcomes of patients with non-ischemic cardiomyopathy: a prespecified interim analysis of the BIO-LIBRA studyResearch in context
by: Valentina Kutyifa, et al.
Published: (2025-08-01)

Long-term outcomes of cardiac resynchronization therapy and implantable cardioverter defibrillators in elderly patients with heart failure
by: Yanxiao Su, et al.
Published: (2025-06-01)

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

Importance of blood biomarker determination in the selection of patients with heart failure for cardioverterdefibrillator implantation
by: N. N. Ilov, et al.
Published: (2023-11-01)

The Advances in Diagnosis and Treatment of Brugada Syndrome: A Comprehensive Review
by: Bartosz Szepietowski, et al.
Published: (2025-07-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

Magnetic resonance-conditional cardiac implantable electronic devices: an Italian perspective on the prevalence of mixed-brand systems over time
by: Davide Saporito, et al.
Published: (2024-11-01)

Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)

Non-compaction cardiomyopathy: clinical forms, outcomes and survival in a cohort of belarusian patients
by: S. M. Komissarova, et al.
Published: (2022-05-01)

Survival benefit of primary prevention implantable cardioverter‐defibrillator/cardiac resynchronization therapy with a defibrillator: Analysis of the Japan cardiac device treatment registry and Japanese cardiac registry of heart failure in cardiology
by: Hisashi Yokoshiki, et al.
Published: (2025-06-01)

Analysis of arrhythmic episodes in patients with implanted cardioverter defibrillators and a high risk of sudden cardiac death
by: A. S. Postol, et al.
Published: (2019-11-01)